rs1064794266
Variant summary
Our verdict is Uncertain significance. The variant received 5 ACMG points: 5P and 0B. PVS1_ModeratePM2PP5
The NM_001267550.2(TTN):c.53287+1G>T variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001267550.2 splice_donor, intron
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 5 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001267550.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TTN | NM_001267550.2 | MANE Select | c.53287+1G>T | splice_donor intron | N/A | NP_001254479.2 | |||
| TTN | NM_001256850.1 | c.48364+1G>T | splice_donor intron | N/A | NP_001243779.1 | ||||
| TTN | NM_133378.4 | c.45583+1G>T | splice_donor intron | N/A | NP_596869.4 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TTN | ENST00000589042.5 | TSL:5 MANE Select | c.53287+1G>T | splice_donor intron | N/A | ENSP00000467141.1 | |||
| TTN | ENST00000446966.2 | TSL:1 | c.53131+1G>T | splice_donor intron | N/A | ENSP00000408004.2 | |||
| TTN | ENST00000436599.2 | TSL:1 | c.53011+1G>T | splice_donor intron | N/A | ENSP00000405517.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Canonical splice site variant predicted to result in an in-frame loss of the adjacent exon in a gene for which loss of function is a known mechanism of disease; Located in the A-band, a region of TTN for which truncating variants are significantly associated with autosomal dominant cardiomyopathy and also with autosomal recessive skeletal myopathies (PMID: 22335739, 32778822); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 32964742, 22335739, 34461741, 38438525, 32778822)
Cardiovascular phenotype Uncertain:1
The c.26092+1G>T intronic variant results from a G to T substitution one nucleotide after coding exon 104 of the TTN gene. Coding exon 104 is located in the A-band region of the N2-B isoform of the titin protein and is constitutively expressed in TTN transcripts (percent spliced in or PSI 100%). This variant (referred to as c.48364+1G>T) has been detected in an individual from a dilated cardiomyopathy cohort (Herman DS et al. N Engl J Med, 2012 Feb;366:619-28). This nucleotide position is highly conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will weaken the native splice donor site and will result in the creation or strengthening of a novel splice donor site. The resulting transcript is predicted to be in-frame and is not expected to trigger nonsense-mediated mRNA decay. The exact functional effect of the missing amino acids is unknown. Based on the available evidence, the clinical significance of this alteration remains unclear.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at